quantitative
Analysis v1
Strong Support
Taking a drug called retatrutide once a week might lower blood pressure in people with obesity or type 2 diabetes, which could help protect their heart over time.
57
0
Evidence from Studies
Supporting (1)
57
Community contributions welcome
57
Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials
Systematic Review With Meta-Analysis
Human
2025The study looked at people with obesity who took retatrutide weekly and found their blood pressure dropped by the exact amounts claimed, so the study supports the claim.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.